BIOT
Biotech Acquisition Company Class A Ordinary Shares
BIOT
BIOT
Delisted
BIOT was delisted on the 2nd of February, 2023.
67 hedge funds and large institutions have $218M invested in Biotech Acquisition Company Class A Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
Holders
67
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$20M | |
| 2 | +$7.44M | |
| 3 | +$6.3M | |
| 4 |
RL
RPO LLC
Stamford,
Connecticut
|
+$4.54M |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$2.47M |
Top Sellers
| 1 | -$8.33M | |
| 2 | -$7.42M | |
| 3 | -$4.93M | |
| 4 |
DCM
DG Capital Management
New York
|
-$4.43M |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$2.56M |